Table 2.
Demography | Responders (R, n = 25) |
Non-Responders (NR, n = 32) | Controls (C, n = 10) |
p Value (R~NR) |
p Value (C~R + NR) |
Clinical Benefit (CB, n = 34) |
No Clinical Benefit (NB, n = 23) |
p Value (CB~NB) |
---|---|---|---|---|---|---|---|---|
Sex, (n) | 0.163 a | 0.191 a | 0.401 a | |||||
Male | 14 | 24 | 5 | 21 | 17 | |||
Female | 11 | 8 | 5 | 13 | 6 | |||
Age (years), median (range) | 64 (40–84) | 67.5 (32–92) | 52.5 (36–67) | 0.239 b 0.183 a |
0.0193 b 0.073 a |
63 (32–85) | 70 (38–92) | 0.163 b 0.578 a |
31–40 | 0 | 2 | 1 | 1 | 1 | |||
41–50 | 4 | 0 | 2 | 4 | 0 | |||
51–60 | 5 | 6 | 3 | 7 | 4 | |||
61–70 | 7 | 7 | 4 | 9 | 5 | |||
71–80 | 7 | 9 | 0 | 8 | 8 | |||
>80 | 2 | 6 | 0 | 4 | 4 | |||
BMI, median (range) | 27.8 (20–34.9) | 27.5 (17.5–56.2) | 25.1 (19.1–29) | 0.526 b 0.497 a |
0.273 b 0.194 a |
27.1 (20–41.9) | 27.8 (17.5–56.2) | 0.612 b 0.401 a |
Underweight (<18.5 kg/m2) | 0 | 1 | 0 | 0 | 1 | |||
Normal (18.5–24.9 kg/m2) | 9 | 6 | 5 | 5 | 2 | |||
Overweight (25.0–29.9 kg/m2) | 9 | 13 | 5 | 6 | 2 | |||
Obese (≥30 kg/m2) | 7 | 10 | 0 | 22 | 17 | |||
Blood group: | 0.635 a | 0.407 a | 0.323 a | |||||
O | 6 | 3 | 1 | 6 | 3 | |||
A | 8 | 10 | 3 | 13 | 5 | |||
AB | 1 | 2 | 3 | 1 | 2 | |||
B | 6 | 9 | 2 | 7 | 8 | |||
Blood Rh-type: | 0.101 a | 0.127 a | 0.041 a | |||||
“−” | 3 | 9 | 4 | 4 | 8 | |||
“+” | 18 | 15 | 5 | 23 | 10 | |||
Antibiotic treatment: | 0.804 a | 0.455 a | 0.850 a | |||||
During last 2 months | 3 | 2 | 0 | 4 | 1 | |||
2–6 months ago | 6 | 6 | 0 | 8 | 4 | |||
6–12 months ago | 3 | 6 | 2 | 5 | 4 | |||
Over 12 months ago | 11 | 13 | 8 | 14 | 10 | |||
PPI usage: | 1.0 a | 0.889 a | 1.0 a | |||||
No | 20 | 26 | 8 | 27 | 19 | |||
Occasionally | 3 | 3 | 2 | 4 | 2 | |||
Regularly | 1 | 1 | 0 | 1 | 1 | |||
Antacid usage: | 0.687 a | 0.267 a | 1.0 a | |||||
No | 21 | 26 | 7 | 27 | 20 | |||
Occasionally | 2 | 4 | 3 | 4 | 2 | |||
Regularly | 0 | 0 | 0 | 1 | 0 | |||
Oral NSAID usage: | 0.837 a | 0.523 a | 0.767 a | |||||
No | 13 | 15 | 3 | 18 | 10 | |||
Occasionally | 11 | 12 | 7 | 13 | 10 | |||
Regularly | 1 | 3 | 0 | 2 | 2 | |||
Low-dose ASA: | 0.741 a | 0.825 a | 1.0 a | |||||
No | 21 | 24 | 9 | 27 | 18 | |||
Yes | 4 | 6 | 1 | 6 | 4 | |||
Birth: | 1.0 a | 0.907 a | 0.738 a | |||||
Natural | 24 | 29 | 9 | 32 | 21 | |||
Caesarean section | 0 | 1 | 0 | 0 | 1 | |||
Birthplace: | 0.264 a | 0.058 a | 0.172 a | |||||
Home | 9 | 14 | 3 | 12 | 11 | |||
Hospital | 16 | 12 | 7 | 20 | 8 | |||
Breastfed: | 1.0 a | 1.0 a | 1.0 a | |||||
No | 0 | 0 | 0 | 0 | 0 | |||
Yes | 19 | 22 | 6 | 23 | 23 | |||
Breastfed duration (months): | 0.785 a 0.670 a,h |
0.708 a 1.0 a,h |
0.829 a 0.547 a,h |
|||||
24 | 8 | 9 | 2 | 10 | 7 | |||
1 | 8 | 6 | 4 | 8 | 6 | |||
0.25 | 1 | 0 | 0 | 1 | 0 | |||
0.1 | 0 | 1 | 0 | 0 | 1 | |||
Prevailing dietary fat type: | 0.033 a | 0.092 a | 0.064 a | |||||
Plant-based | 12 | 19 | 7 | 16 | 15 | |||
Mixed | 9 | 2 | 1 | 10 | 1 | |||
Animal-based | 4 | 8 | 2 | 7 | 5 | |||
Meat portions consumed: | 0.53 a | 0.391 a | 0.801 a | |||||
1 or fewer weekly | 5 | 4 | 4 | 5 | 4 | |||
2–6 weekly | 15 | 23 | 6 | 22 | 16 | |||
1 or more daily | 3 | 2 | 0 | 4 | 1 | |||
Vegetable portions consumed: | 0.705 a | 0.695 a | 0.523 a | |||||
1 or fewer daily | 6 | 5 | 1 | 6 | 5 | |||
2–3 daily | 13 | 19 | 5 | 18 | 14 | |||
4–5 daily | 6 | 6 | 4 | 9 | 3 | |||
Over 5 daily | 0 | 0 | 0 | 0 | 0 | |||
Fruit portions consumed: | 0.768 a | 0.948 a | 0.422 a | |||||
1 or fewer daily | 8 | 7 | 3 | 10 | 5 | |||
2–3 daily | 13 | 20 | 6 | 17 | 16 | |||
4–5 daily | 3 | 2 | 1 | 4 | 1 | |||
Over 5 daily | 1 | 1 | 0 | 2 | 0 | |||
Plant portions consumed c: | 0.082 a 0.058 a,d 0.041 a,e 0.033 a,d,e |
0.190 a 0.132 a,d 0.041 a,e 0.032 a,d,e |
0.031 a 0.044 a,d 0.041 a,e 0.032 a,d,e |
|||||
Low | 2 | 11 | 1 | 4 | 9 | |||
Recommended | 10 | 14 | 5 | 13 | 11 | |||
High | 7 | 5 | 3 | 10 | 2 | |||
Fermented veg. consumption: | 0.835 a | 0.815 a 0.403 a,d |
1.0 a 0.820 a,d |
|||||
No | 3 | 2 | 0 | 3 | 2 | |||
Rarely | 6 | 8 | 4 | 8 | 6 | |||
Often | 16 | 20 | 6 | 22 | 14 | |||
Salt consumption: | 0.316 a | 0.596 a | 0.216 a | |||||
Low | 10 | 12 | 5 | 12 | 10 | |||
Average | 14 | 13 | 4 | 19 | 8 | |||
High | 1 | 5 | 1 | 2 | 4 | |||
Dairy portions consumed: | 0.072 a 0.050 a,g |
0.217 a | 0.037 a 0.024 a,g |
|||||
1 or fewer daily | 14 | 8 | 4 | 17 | 5 | |||
2–3 daily | 10 | 19 | 5 | 13 | 16 | |||
4–5 daily | 1 | 1 | 1 | 1 | 1 | |||
Over 5 daily | 0 | 2 | 0 | 2 | 0 | |||
Bread type consumption: | 0.55 a 0.200 a,d |
0.744 a 0.507 a,d |
0.181 a 0.266 a,d |
|||||
Light only | 2 | 5 | 1 | 4 | 3 | |||
Mostly white | 9 | 13 | 6 | 11 | 11 | |||
Mostly wholemeal | 11 | 8 | 2 | 15 | 4 | |||
Wholemeal only | 2 | 3 | 1 | 2 | 3 | |||
Cereal consumption: | 0.93 a 0.821 a,d 0.764 a,h |
0.866 a 0.581 a,d |
0.769 a 0.725 a,d 0.547 a,h |
|||||
Breakfast cereals, white rice | 3 | 3 | 0 | 3 | 3 | |||
Mostly listed above | 6 | 5 | 3 | 7 | 4 | |||
Mostly listed below | 5 | 8 | 1 | 8 | 5 | |||
Oatmeal, muesli, brown rice | 9 | 9 | 4 | 13 | 5 | |||
Beverage sweetening habits: | 0.293 a | 0.366 a 0.194 a,d |
0.353 a 0.164 a,d |
|||||
Do not sweeten | 12 | 20 | 7 | 18 | 14 | |||
Use artificial sweetener | 1 | 2 | 1 | 1 | 2 | |||
Use sugar | 12 | 8 | 2 | 14 | 6 | |||
Soft drink consumption: | 0.71 a | 0.469 a 0.446 a,d |
0.976 a 0.909 a,d |
|||||
1 or fewer servings/month | 10 | 14 | 5 | 15 | 9 | |||
2–3 servings/month | 3 | 6 | 4 | 5 | 4 | |||
1–3 servings/week | 5 | 6 | 0 | 6 | 5 | |||
More than 3 servings/week | 5 | 3 | 1 | 5 | 3 | |||
Defecation frequency: | 0.01 a | 0.038 a | 0.720 a | |||||
Twice or more per day | 5 | 4 | 3 | 3 | 1 | |||
Once a day | 15 | 13 | 5 | 6 | 7 | |||
Every second day | 1 | 12 | 2 | 17 | 11 | |||
Seldom | 3 | 1 | 0 | 6 | 3 | |||
Bristol Stool Form Scale: | 0.689 a | 0.713 a | 0.747 a | |||||
Type 1 | 1 | 5 | 2 | 3 | 3 | |||
Type 2 | 2 | 2 | 0 | 3 | 1 | |||
Type 3 | 3 | 6 | 2 | 9 | 3 | |||
Type 4 | 13 | 14 | 5 | 15 | 12 | |||
Type 5 | 2 | 2 | 0 | 2 | 2 | |||
Type 6 | 0 | 0 | 0 | 0 | 0 | |||
Type 7 | 0 | 0 | 1 | 0 | 0 | |||
Diet alterations: | 0.362 a | 0.182 a | 0.373 a | |||||
No | 23 | 25 | 8 | 30 | 18 | |||
Yes, during last 2 weeks | 1 | 4 | 1 | 0 | 0 | |||
Yes, during last month | 0 | 0 | 1 | 0 | 0 | |||
Yes, over 1 month ago | 0 | 0 | 0 | 2 | 3 | |||
Current probiotics use: | 1.0 a | 1.0 a | 0.362 a | |||||
No | 21 | 23 | 9 | 28 | 16 | |||
Yes | 2 | 3 | 1 | 2 | 3 | |||
Probiotic use history: | 0.649 a | 0.740 a | 0.218 a | |||||
In last 2–3 weeks | 0 | 1 | 1 | 0 | 1 | |||
Over 3 weeks ago | 1 | 2 | 0 | 3 | 0 | |||
In last 6 months | 1 | 2 | 1 | 2 | 1 | |||
Over 6 months ago | 3 | 1 | 3 | 4 | 0 | |||
Tobacco smoking: | 1.0 a | 0.494 a | 1.0 a | |||||
No | 20 | 26 | 7 | 27 | 19 | |||
Yes | 4 | 4 | 3 | 5 | 3 | |||
Smoking cessation: | 1.0 a | 0.339 a | 0.251 a | |||||
Less than 1 year ago | 0 | 1 | 0 | 0 | 1 | |||
1 to 2 years ago | 1 | 1 | 1 | 2 | 0 | |||
Over 2 years ago | 7 | 8 | 3 | 10 | 5 | |||
Alcohol consumption history: | 0.253 a | 0.430 a | 0.740 a | |||||
Never | 3 | 5 | 1 | 5 | 3 | |||
In the past | 8 | 12 | 3 | 11 | 9 | |||
Currently | 14 | 8 | 6 | 15 | 7 | |||
Alcohol consumption freq. f: | 0.495 a | 0.748 a | 0.491 a | |||||
1 or fewer servings/month | 6 | 1 | 0 | 6 | 1 | |||
2–4 servings/month | 5 | 4 | 3 | 6 | 3 | |||
1–6 servings/week | 1 | 2 | 2 | 1 | 2 | |||
1–2 servings/day | 1 | 1 | 0 | 1 | 1 | |||
3 or more servings/day | 1 | 0 | 0 | 1 | 0 |
NSAID, non-steroidal anti-inflammatory drugs; PPI, proton pump inhibitor. a Fisher’s exact test. b Kruskal–Wallis test. c Pooled categories of vegetable and fruit portions. d Only those that declared no diet change. e For low versus high. f In group declaring present alcohol consumption. g For ‘1 or fewer servings daily’ versus ‘2–3 servings daily’. h Collapsed to 2 categories.